ACCURAY INCORPORATED Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent
ACCURAY INCORPORATED (ARAY) had Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent of $1.73 million as of 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments and Receivables, Net › Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent
us-gaap:LongTermAccountsNotesAndLoansReceivableNetNoncurrent · last filed 2025-11-05
- 2025-09-30: Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent $1.73M.
- 2025-06-30: Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent $2.76M.
- 2025-03-31: Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent $2.35M.
- 2024-12-31: Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent $2.25M.
| Period end | Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent |
|---|---|
| 2025-09-30 | $1.73M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.76M 10-Q · filed 2025-11-05 |
| 2025-03-31 | $2.35M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $2.25M 10-Q · filed 2025-02-05 |
| 2024-09-30 | $2.41M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $1.53M 10-K · filed 2025-08-28 |
| 2024-03-31 | $1.90M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.31M 10-Q · filed 2024-02-07 |
| 2023-09-30 | $2.36M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $3.04M 10-K · filed 2024-09-19 |
| 2023-03-31 | $2.79M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $2.98M 10-Q · filed 2023-02-02 |
| 2022-09-30 | $2.57M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $2.76M 10-K · filed 2023-09-07 |
| 2022-03-31 | $2.76M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $2.89M 10-Q · filed 2022-01-28 |
| 2021-09-30 | $3.14M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $3.39M 10-K · filed 2022-08-17 |
| 2021-03-31 | $3.33M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $5.34M 10-Q · filed 2021-02-01 |
| 2020-09-30 | $3.52M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $3.79M 10-K · filed 2021-08-17 |
| 2020-03-31 | $4.30M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $3.40M 10-Q · filed 2020-02-04 |
| 2019-09-30 | $3.10M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $4.27M 10-K · filed 2020-08-25 |
| 2019-03-31 | $3.81M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $4.83M 10-Q · filed 2019-02-08 |
| 2018-09-30 | $4.19M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $6.89M 10-K · filed 2019-08-23 |
| 2018-03-31 | $8.20M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $7.99M 10-Q · filed 2018-02-05 |
| 2017-09-30 | $8.96M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $7.43M 10-K · filed 2018-08-24 |
| 2017-03-31 | $5.46M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $6.00M 10-Q · filed 2017-02-03 |
| 2016-09-30 | $7.01M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $7.60M 10-K · filed 2017-08-25 |
| 2015-06-30 | $1.64M 10-K · filed 2016-08-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |